Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer

Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal cancer who have registered progression or intolerance to treatment with fluoropyrimidines, oxaliplatin and irinotecan, anti-VEGRand anti-EGF...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: M. Yu. Fedyanin, F. V. Moiseenko, D. A. Chekini, V. A. Chubenko, A. S. Zhabina, L. A. Zagorskaya, M. M. Kramchaninov, S. A. Tjulandin, V. M. Moiseyenko
Formáid: Artigo
Teanga:Russo
Foilsithe: Remedium Group LLC 2020-12-01
Sraith:Медицинский совет
Ábhair:
trifluridine/tipiracil
tas-102
metastatic cancer
colorectal
chemotherapy
targeted therapy
Rochtain Ar Líne:https://www.med-sovet.pro/jour/article/view/5934
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla